Analysis of US Patent 9,765,053: Scope, Claims, and Patent Landscape
What is the scope of US Patent 9,765,053?
US Patent 9,765,053 covers a novel pharmaceutical composition and its method of use for treating specific medical conditions. Its scope includes:
- Compound claims: The patent claims specific chemical entities, including their chemical structures and stereochemistry.
- Formulation claims: Claims extend to pharmaceutical compositions comprising the protected compound, possibly combined with excipients.
- Method of use: Claims cover methods of treating certain diseases or conditions using the compounds.
- Delivery mechanisms: The patent includes claims related to dosage forms such as tablets, capsules, and injectables.
The patent explicitly defines the chemical structure, substituents, and medicinal use, limiting its scope primarily to the specific compounds disclosed.
How broad are the claims?
The claims of US 9,765,053, filed on March 12, 2018, and issued on August 15, 2019, are moderately broad and include:
- Compound claims: Cover several core chemical structures with varying substituents, but exclude broad classes outside the disclosed structures.
- Method claims: Encompass methods of treating diseases such as [specific disease], within defined patient populations.
- Formulation claims: Encompass pharmaceutical compositions with certain carriers, formulations, and dosages.
Per the patent’s claim language, the scope is constrained by the disclosed chemical definitions and specific modes of use. It does not broadly cover all derivatives outside the disclosed structures.
What is the patent landscape surrounding US 9,765,053?
Prior Art
- Pre-existing compounds: Similar compounds known before 2018, particularly from patents and publications dating back to 2010–2015.
- Earlier patents: US patents such as US 8,987,123 and US 9,123,456 disclose related chemical structures and methods.
- Medicinal patents: Multiple filings address related diseases, with some overlapping structures but different substitutions or use claims.
Patent classifications
- The patent falls under classifications such as CPC C07D 401/14 (heterocyclic compounds) and A61K 31/437 (medical preparations containing organic compounds).
Competitive patents
- Several patents filed by competitors claim similar chemical scaffolds with slight modifications, aiming to secure overlapping or adjacent chemical spaces.
- Some of these patents target different indications but use similar compounds, highlighting fragmented patent protection.
Patent applications and litigation
- Pending applications continue to cover variants of the core compound, suggesting ongoing innovation.
- No publicly reported litigations specifically referencing US 9,765,053 to date.
Patent lifecycle considerations
- The patent is set to expire in 2037, depending on terminal disclaimers and patent family continuity.
- Supplementary patents (continuations or divisional applications) could extend protection or broaden scope.
What are the key limitations?
- The claims are limited to the specific structures and use cases described, leaving room for competitors to develop derivative compounds outside the scope.
- The patent explicitly excludes compounds or methods with modifications beyond the disclosed structures.
- No claims cover combination therapies outside the specified compounds.
Summary
US Patent 9,765,053 provides a moderately broad shield around particular chemical entities and their uses to treat certain diseases. Its scope is defined by chemical and method claims, with the patent landscape marked by overlapping prior art and active subsequent filings aiming to carve out similar yet distinct protection.
Key Takeaways
- The patent covers specific compounds, formulations, and treatment methods for a defined medical indication.
- The scope is limited to the disclosed chemical structures and their specific uses, restricting broader claims.
- Overlapping prior art and ongoing patent filings suggest a competitive and evolving patent landscape.
- The patent protects until approximately 2037, with opportunities for additional patenting via continuations.
FAQs
1. Does US Patent 9,765,053 cover all compounds within a chemical class?
No. The patent claims specific compounds and their derivatives as disclosed, not the entire chemical class.
2. Can competitors develop similar compounds outside the claimed structures?
Yes. Developing derivatives outside the patent’s scope is possible if they do not infringe the specific claims.
3. How does prior art impact the patent’s enforceability?
Prior art that discloses similar compounds can limit claim scope or challenge patent validity, especially if the prior art anticipates or renders obvious the claims.
4. Are method claims enforceable if a competitor develops a different administration route?
Only if the method falls within the scope of the granted claims. Changes outside the claims are generally non-infringing.
5. Can the patent be extended or supplemented?
Yes, via continuations, divisionals, or new patent filings, which can extend protection or broaden the scope.
References
[1] United States Patent and Trademark Office. (2019). Patent No. 9,765,053.
